DOI QR코드

DOI QR Code

Extracellular Nucleotides Can Induce Chemokine (C-C motif) Ligand 2 Expression in Human Vascular Smooth Muscle Cells

  • Kim, Jeung-Il (Department of Orthopedic Surgery, Pusan National University Hospital) ;
  • Kim, Hye-Young (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Kim, Sun-Mi (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Lee, Sae-A (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Son, Yong-Hae (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Eo, Seong-Kug (Laboratory of Microbiology, College of Veterinary Medicine and Bio-Safety Research Institute, Chonbuk National University) ;
  • Rhim, Byung-Yong (Department of Pharmacology, School of Medicine, Pusan National University) ;
  • Kim, Koanhoi (Department of Pharmacology, School of Medicine, Pusan National University)
  • Received : 2011.01.17
  • Accepted : 2011.02.19
  • Published : 2011.02.28

Abstract

To understand the roles of purinergic receptors and cellular molecules below the receptors in the vascular inflammatory response, we determined if extracellular nucleotides up-regulated chemokine expression in vascular smooth muscle cells (VSMCs). Human aortic smooth muscle cells (AoSMCs) abundantly express $PSY_1$, $PSY_6$, and $PSY_{11}$ receptors, which all respond to extracellular nucleotides. Exposure of human AoSMCs to $NAD^+$, an agonist of the human $PSY_{11}$ receptor, and $NADP^+$ as well as ATP, an agonist for $PSY_1$ and $PSY_{11}$ receptors, caused increase in chemokine (C-C motif) ligand 2 gene (CCL2) transcript and CCL2 release; however, UPT did not affect CCL2 expression. CCL2 release by $NAD^+$ and $NADP^+$ was inhibited by a concentration dependent manner by suramin, an antagonist of P2-purinergic receptors. $NAD^+$ and $NADP^+$ activated protein kinase C and enhanced phosphorylation of mitogen-activated protein kinases and Akt. $NAD^+$- and $NADP^+$-mediated CCL2 release was significantly attenuated by SP6001250, U0126, LY294002, Akt inhibitor IV, RO318220, GF109203X, and diphenyleneiodium chloride. These results indicate that extracellular nucleotides can promote the proinflammatory VSMC phenotype by up-regulating CCL2 expression, and that multiple cellular elements, including phosphatidylinositol 3-kinase, Akt, protein kinase C, and mitogen-activated protein kinases, are involved in that process.

Keywords

References

  1. Aukrust P, Halvorsen B, Yndestad A, Ueland T, Oie E, Otterdal K, Gullestad L, Damas JK. Chemokines and cardiovascular risk. Arterioscler Thromb Vasc Biol. 2008;28:1909-1919. https://doi.org/10.1161/ATVBAHA.107.161240
  2. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508-519. https://doi.org/10.1038/nri1882
  3. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res. 2009;29:313-326. https://doi.org/10.1089/jir.2008.0027
  4. Ohtsuki K, Hayase M, Akashi K, Kopiwoda S, Strauss HW. Detection of monocyte chemoattractant protein-1 receptor expression in experimental atherosclerotic lesions: an autoradiographic study. Circulation. 2001;104:203-208. https://doi.org/10.1161/01.CIR.104.2.203
  5. Takeya M, Yoshimura T, Leonard EJ, Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol. 1993;24:534-539. https://doi.org/10.1016/0046-8177(93)90166-E
  6. Boisvert WA, Santiago R, Curtiss LK, Terkeltaub RA. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J Clin Invest. 1998;101:353-363. https://doi.org/10.1172/JCI1195
  7. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, Rollins BJ, Charo IF. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest. 1999;103:773-778. https://doi.org/10.1172/JCI5624
  8. Burnstock G. The past, present and future of purine nucleotides as signalling molecules. Neuropharmacology. 1997;36:1127-1139. https://doi.org/10.1016/S0028-3908(97)00125-1
  9. Communi D, Janssens R, Suarez-Huerta N, Robaye B, Boeynaems JM. Advances in signalling by extracellular nucleotides. the role and transduction mechanisms of P2Y receptors. Cell Signal. 2000;12:351-360. https://doi.org/10.1016/S0898-6568(00)00083-8
  10. Burnstock G. Purinergic regulation of vascular tone and remodelling. Auton Autacoid Pharmacol. 2009;29:63-72. https://doi.org/10.1111/j.1474-8673.2009.00435.x
  11. Dawicki DD, Chatterjee D, Wyche J, Rounds S. Extracellular ATP and adenosine cause apoptosis of pulmonary artery endothelial cells. Am J Physiol. 1997;273:L485-494.
  12. Malam-Souley R, Seye C, Gadeau AP, Loirand G, Pillois X, Campan M, Pacaud P, Desgranges C. Nucleotide receptor P2u partially mediates ATP-induced cell cycle progression of aortic smooth muscle cells. J Cell Physiol. 1996;166:57-65. https://doi.org/10.1002/(SICI)1097-4652(199601)166:1<57::AID-JCP7>3.0.CO;2-F
  13. Zheng LM, Zychlinsky A, Liu CC, Ojcius DM, Young JD. Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol. 1991;112:279-288. https://doi.org/10.1083/jcb.112.2.279
  14. Choi KH, Park JW, Kim HY, Kim YH, Kim SM, Son YH, Park YC, Eo SK, Kim K. Cellular factors involved in CXCL8 expression induced by glycated serum albumin in vascular smooth muscle cells. Atherosclerosis. 2010;209:58-65. https://doi.org/10.1016/j.atherosclerosis.2009.08.030
  15. Wang L, Karlsson L, Moses S, Hultgardh-Nilsson A, Andersson M, Borna C, Gudbjartsson T, Jern S, Erlinge D. P2 receptor expression profiles in human vascular smooth muscle and endothelial cells. J Cardiovasc Pharmacol. 2002;40:841-853. https://doi.org/10.1097/00005344-200212000-00005
  16. Sung SC, Kim K, Lee KA, Choi KH, Kim SM, Son YH, Moon YS, Eo SK, Rhim BY. 7-Ketocholesterol upregulates interleukin- 6 via mechanisms that are distinct from those of tumor necrosis factor-alpha, in vascular smooth muscle cells. J Vasc Res. 2009;46:36-44. https://doi.org/10.1159/000135663
  17. Chung SW, Park JW, Lee SA, Eo SK, Kim K. Thrombin promotes proinflammatory phenotype in human vascular smooth muscle cell. Biochem Biophys Res Commun. 2010;396:748-754. https://doi.org/10.1016/j.bbrc.2010.05.009
  18. Harper S, Webb TE, Charlton SJ, Ng LL, Boarder MR. Evidence that P2Y4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP. Br J Pharmacol. 1998;124:703-710. https://doi.org/10.1038/sj.bjp.0701895
  19. Wilden PA, Agazie YM, Kaufman R, Halenda SP. ATPstimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am J Physiol. 1998; 275:H1209-1215.
  20. Zhang W, Liu HT. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002;12:9-18. https://doi.org/10.1038/sj.cr.7290105
  21. Hou M, Moller S, Edvinsson L, Erlinge D. Cytokines induce upregulation of vascular P2Y(2) receptors and increased mitogenic responses to UTP and ATP. Arterioscler Thromb Vasc Biol. 2000;20:2064-2069. https://doi.org/10.1161/01.ATV.20.9.2064
  22. Yu SM, Chen SF, Lau YT, Yang CM, Chen JC. Mechanism of extracellular ATP-induced proliferation of vascular smooth muscle cells. Mol Pharmacol. 1996;50:1000-1009.
  23. Needleman P, Minkes MS, Douglas JR Jr. Stimulation of prostaglandin biosynthesis by adenine nucleotides. Profile of prostaglandin release by perfused organs. Circ Res. 1974; 34:455-460. https://doi.org/10.1161/01.RES.34.4.455
  24. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension. 2003;42:1075-1081. https://doi.org/10.1161/01.HYP.0000100443.09293.4F

Cited by

  1. Purinergic Signaling and Blood Vessels in Health and Disease vol.66, pp.1, 2014, https://doi.org/10.1124/pr.113.008029
  2. Preventive effect of nucleoprotein on hindlimb unloading-induced capillary regression in rat soleus muscle vol.89, pp.3, 2014, https://doi.org/10.3109/10520295.2013.835444